---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-307381"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:20:58.561838+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Minerva Neurosciences amends CEO Luthringer's employment agreement with enhanced severance terms

## Summary
- CEO Remy Luthringer to receive 12 months base salary continuation upon termination without cause.
- Pro-rata annual bonus (assumed at 50% of base salary) + accelerated vesting for awards vesting within 6 months.
- Base salary set at $600,096 per year.
- Amendment effective December 13, 2022.

## SEC filing metadata
- accession: 0001193125-22-307381
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312522307381/0001193125-22-307381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312522307381/d438557d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-307381
- JSON: https://secwatch.observer/filing/0001193125-22-307381.json
- Plain text: https://secwatch.observer/filing/0001193125-22-307381.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.